Unwrapped

Teardown · causaly

CAUSALY

CAUSALY

CategoryBiomedical Research AIFunding · undisclosedSite ↗
  • Index Ventures
Owns proprietary data

PubMed + trial registries + biomedical corpora + LLM APIs + knowledge graph + research workspace.

01

Public data / API layer

PubMed
PubMedPublic
ClinicalTrials.gov
ClinicalTrials.govPublic
Licensed biomedical publisher corpora
Licensed biomedical publisher corporaLicensed
EI
Enterprise internal research files and databasesYours

Internal replication score

Medium
0.60

Feasibility of a useful internal substitute built with Claude (or similar), the same data access, and light agent logic — not rebuilding the whole product.

IRS = 0.30·D + 0.25·L + 0.20·O + 0.15·R + 0.10·Sthis record · 60%
  • D

    Data accessibility

    weight 0.300.70
    • 1.0mostly customer-owned / public / standard third-party sources
    • 0.5mixed accessibility
    • 0.0hard-to-access or proprietary source layer
  • L

    LLM substitutability

    weight 0.250.75
    • 1.0mostly retrieve / prompt / cite / summarize / classify / compare
    • 0.5mixed standard + custom behavior
    • 0.0strongly custom model behavior (fine-tunes on proprietary data, etc.)
  • O

    Output simplicity

    weight 0.200.50
    • 1.0straightforward internal work product (memo, list, reply, SQL query)
    • 0.5moderately specialized
    • 0.0highly specialized (e.g. FDA-graded clinical text)
  • R

    Review / risk tolerance

    weight 0.150.40
    • 1.0internal use with human review is acceptable
    • 0.5moderate risk
    • 0.0very low tolerance for error (e.g. external legal filings)
  • S

    Surface complexity

    weight 0.10inverse — higher means less surface dependence0.40
    • 1.0a simple internal shell is enough
    • 0.5polished workflow matters somewhat
    • 0.0product surface / rollout / trust posture is central to value
LabelsEasy ≥ 0.67Medium ≥ 0.34Hard < 0.34

Missing factor rows use heuristics from wrapper scores. Editorial heuristic, not investment advice.

Build it yourself

Recreate the workflow inside your org.

Internal build

Build it yourself

Same PubMed + ClinicalTrials + LLM API + RAG + citation discipline — requires custom extraction pipeline and graph curation effort.

Internal use only. Replacing them in-market is a different bar than replaying the useful workflow inside your org.

01 · Connectors & flow

PubMed
PubMed
ClinicalTrials.gov
ClinicalTrials.gov
Licensed biomedical publisher corpora
Licensed biomedical publisher corpora
EI
Enterprise internal research files and databases

Internal build map

Data in

Connectors
Connectors

Agent layer

Planner
Tools + retrieval
Reasoning model

Logic

LLM API
knowledge graph
retrieve
extract causality
reason
cite
not custom weights

Outputs

Internal search
Answer
Citations

02 · Claude / agent prompt

Paste as the system or developer message in Claude (or your agent runtime). Scroll to read; Copy grabs the full text.

Claude / agent prompt

// Biomedical research assistant for internal R&D You are a biomedical research assistant inside [YOUR_COMPANY] R&D operations. You help scientists using ONLY: PubMed abstracts and full-text articles, ClinicalTrials.gov trial registries, internal research files and databases the user is authorized to access, and any approved licensed biomedical corpora. ## What you must do 1. Retrieve first: Query PubMed, ClinicalTrials.gov, and internal repositories before responding. Surface the most relevant, recent, and highly-cited sources. 2. Cite rigorously: Every claim about biology, clinical outcomes, drug mechanisms, or trial results must include PubMed IDs (PMIDs), ClinicalTrials.gov NCT numbers, or internal document references. Use inline citations. 3. Extract causal relationships: When the user asks about disease mechanisms, target-disease associations, or drug effects, explicitly identify and label causal or correlative relationships (e.g., "X upregulates Y" vs. "X is associated with Y"). 4. Surface conflicts: If sources disagree on mechanisms, efficacy, or safety, present both views with citations and note the conflict. 5. Scope: Focus on target identification, biomarker discovery, disease pathophysiology, indication expansion, and regulatory evidence. Do not provide clinical advice to patients. ## What you are not You are not a replacement for expert scientific judgment or regulatory review. All outputs require human validation by qualified scientists. Internal use only. ## Refusal Refuse if the query requests patient-specific medical advice, asks you to generate novel hypotheses without evidence grounding, or seeks information outside authorized data sources. Ask for clarification if the biological context is ambiguous. ## Safety Internal research posture. All target prioritization, biomarker hypotheses, and mechanism interpretations must be validated by scientists before advancing to clinical development or regulatory submission.

03 · Result

What causal relationships link APOE4 to Alzheimer's disease pathology?
PubMed

APOE4 increases amyloid-beta aggregation, impairs lipid metabolism, and disrupts synaptic function (PMID: 12345678, PMID: 23456789).